Barzilai University Medical Center
Ashkelon, 7830604, Israel
NCT Number: NCT07377461
Kidney stones located in the kidney are commonly treated using a minimally invasive procedure called retrograde intrarenal surgery (RIRS). During this procedure, a ureteral access sheath is often used to facilitate repeated access to the kidney, improve visualization, and allow irrigation fluid to drain.
Newer access sheaths have been developed with flexible distal tips and built-in suction capabilities, which may help reduce operative time by improving visibility and removing stone fragments and irrigation fluid more efficiently.
This prospective randomized study compared a flexible and navigable suction ureteral access sheath with a conventional ureteral access sheath in adult patients undergoing RIRS for kidney stones measuring 10 mm or larger. Participants were randomly assigned to one of the two access sheath types.
The primary objective of the study was to evaluate whether the use of a suction-enabled access sheath reduces operative time. Secondary objectives included assessment of complications, length of hospital stay, stone-free rate, and need for additional interventions.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ashkelon, 7830604, Israel
This was a prospective, single-center, randomized controlled trial conducted at a tertiary referral endourology center. Adult patients (≥18 years) with renal stones measuring 10 mm or greater and scheduled to undergo retrograde intrarenal surgery (RIRS) under general anesthesia were eligible for inclusion.
Participants were randomized in a 1:1 ratio to undergo RIRS using either a flexible and navigable suction ureteral access sheath (FANS group) or a conventional ureteral access sheath (control group). Randomization was performed using a computer-generated sequence with allocation concealment via sealed opaque envelopes. Blinding of the operating surgeon was not feasible due to the nature of the devices used.
All procedures were performed by experienced endourologists using standardized surgical techniques. Flexible ureteroscopy was performed with a digital ureteroscope, and stone fragmentation was achieved using a Holmium:YAG laser in dusting mode. In the suction access sheath group, negative pressure suction was applied through the sheath according to manufacturer guidelines. Irrigation parameters were standardized across both study arms.
The primary outcome measure was operative time, defined as the interval from insertion of the first endoscopic instrument through the urethra to removal of the final instrument at the end of the procedure. Secondary outcome measures included intraoperative and postoperative complications (classified using the Clavien-Dindo system), ureteral wall injury, length of hospital stay, stone migration, and stone-free rate. Stone-free status was defined as the absence of residual fragments greater than 2 mm on postoperative imaging.
Preoperative assessment included non-contrast computed tomography to evaluate stone size, location, and burden. Postoperative imaging was performed using kidney-ureter-bladder radiography or renal ultrasound approximately two weeks after surgery.
The study was approved by the Institutional Review Board of Barzilai University Medical Center, and all participants provided written informed consent prior to enrollment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age 18 years or older
Presence of single or multiple renal stones measuring 10 mm or greater
Eligible for retrograde intrarenal surgery under general anesthesia
Ability to provide written informed consent
Exclusion criteria
Pregnancy
Active urinary tract infection at the time of surgery
Known bleeding disorders
Solitary kidney
Anatomical abnormalities of the urinary tract that could affect ureteroscopic access
Use of a flexible distal-tip ureteral access sheath with integrated suction during retrograde intrarenal surgery to facilitate access, irrigation control, and fragment evacuation.
Use of a standard ureteral access sheath without suction during retrograde intrarenal surgery.
Time frame: During the surgical procedure
Operative time was defined as the duration from insertion of the first endoscopic instrument through the urethra to removal of the final instrument at the end of the procedure.
Time frame: Perioperative period (Day of surgery through postoperative Day 30).
Intraoperative and postoperative complications were recorded and classified according to the Clavien-Dindo classification system.
Time frame: Two weeks after surgery
Stone-free status was defined as the absence of residual stone fragments greater than 2 mm on postoperative imaging.
Time frame: From end of surgery until hospital discharge (typically 1-3 days).
Length of hospital stay was defined as the number of days from surgery to hospital discharge.
Time frame: During the surgical procedure
Ureteral wall injury was assessed intraoperatively and classified according to the Traxer-Thomas classification system.
Barzilai Medical Center
Other
Comparative Study of Access Sheaths With Flexible Tips and Suction Versus Conventional Access in Endourology: A Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02214836
Calculi, Female Urogenital Diseases
Seattle, Washington, United States
View Trial DetailsNCT05365477
Calculi, Female Urogenital Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT07349992
Calculi, Female Urogenital Diseases
Konya, Turkey (Türkiye)
View Trial DetailsNCT07183930
Calculi, Female Urogenital Diseases
Peshawar, Khyber Pakhtunkhwa, Pakistan
View Trial Details